Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype
Overview
Affiliations
Inorganic arsenic is a human carcinogen that can target the prostate. Accumulating evidence suggests arsenic can disrupt stem cell (SC) dynamics during the carcinogenic process. Previous work demonstrated arsenic-transformed prostate epithelial (CAsE-PE) cells can recruit prostate SCs into rapidly acquiring a cancer SC (CSC) phenotype via the secretion of soluble factors. Exosomes are small, membrane-derived vesicles that contain lipids, RNA, and proteins, and actively contribute to cancer initiation and progression when taken up by target cells. Here we hypothesized that CAsE-PE cells are recruiting SCs to a CSC-like phenotype via exosomal signaling. CAsE-PE cells secreted 700% more exosomes than parental RWPE-1 cells. CAsE-PE exosomes were enriched with oncogenic factors, including oncogenes (KRAS, NRAS, VEFGA, MYB, and EGFR), inflammation-related (cyclooxygenase-2, interleukin 1B (IL1B), IL6, transforming growth factor-β, and tumor necrosis factor-A), and apoptosis-related (CASP7, CASP9, and BCL2) transcripts, and oncogenesis-associated microRNAs. When compared with SCs cultured in exosome-depleted conditioned medium (CM), SCs cultured in CM containing CAsE-PE-derived exosomes showed increased (198%) matrix metalloproteinase activity and underwent an epithelial-to-mesenchymal transition in morphology, suggesting an exosome-mediated transformation. KRAS plays an important role in arsenic carcinogenesis. Although KRAS transcript (>24 000%) and protein (866%) levels were elevated in CAsE-PE exosomes, knock-down of KRAS in these cells only partially mitigated the CSC-like phenotype in cocultured SCs. Collectively, these results suggest arsenic impacts both exosomal quantity and cargo. Exosomal KRAS is only minimally involved in this recruitment, and additional factors (eg, cancer-associated miRNAs) likely also play a role. This work furthers our mechanistic understanding of how arsenic disrupts SC dynamics and influences the tumor microenvironment during carcinogenesis.
Arsenic-induced prostate cancer: an enigma.
Mukherjee A, Gopalakrishnan A Med Oncol. 2024; 41(2):50.
PMID: 38184511 DOI: 10.1007/s12032-023-02266-5.
Howe C, Armstrong D, Muse M, Gilbert-Diamond D, Gui J, Hoen A Expo Health. 2023; 15(4):731-743.
PMID: 38074282 PMC: 10707483. DOI: 10.1007/s12403-022-00520-1.
Carberry C, Bangma J, Koval L, Keshava D, Hartwell H, Sokolsky M Toxicol Sci. 2023; .
PMID: 37851381 PMC: 10823775. DOI: 10.1093/toxsci/kfad108.
Exposome and unhealthy aging: environmental drivers from air pollution to occupational exposures.
Pandics T, Major D, Fazekas-Pongor V, Szarvas Z, Peterfi A, Mukli P Geroscience. 2023; 45(6):3381-3408.
PMID: 37688657 PMC: 10643494. DOI: 10.1007/s11357-023-00913-3.
Arsenic disrupts extracellular vesicle-mediated signaling in regenerating myofibers.
Clemens Z, Wang K, Ambrosio F, Barchowsky A Toxicol Sci. 2023; 195(2):231-245.
PMID: 37527016 PMC: 10535782. DOI: 10.1093/toxsci/kfad075.